"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Natco Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : V C Nannapaneni
Home : Natco	Book Value: 461.79599
BSE Code : 524816	Market Cap: 15998.09
NSE Code : NATCOPHARM	P / E : 10.67

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	528.80	1264.30	1192.70	1157.40
Other Income	55.30	93.30	59.60	62.10
Total Income	584.10	1357.60	1252.30	1219.50
Total Expenditure	408.50	711.80	653.00	596.20
Operating Profit	175.60	645.80	599.30	623.30
Interest	8.30	11.70	2.60	8.80
Gross Profit	167.30	634.10	596.70	614.50
Depreciation	42.10	48.10	53.80	93.70
Tax	26.20	130.60	106.00	99.40
Deferred Tax	-7.90	-45.50	-27.20	-6.70
Reported Profit After Tax	106.90	500.90	464.10	428.10

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView